On March 27, the 5th Annual Biolake – Bio-pharmaceutical Salon was held successfully in Wuhan.  This meeting was jointly organized by Shanghai Medicilon Inc. and Wuhan Biolake.  Dr. Chen Chunlin, Medicilon CEO, attended the meeting.  There were total of 40 enterprises and 80 delegates to attend the salon.

Mr. Li Zhe, General Manager of Wuhan Biolake, introduced the latest policy and development of the bio-industry.  Dr. Gu Xingchu and Dr. Chai Guixuan of Medicilon gave the speech on Chinese medicine drug safety evaluation and biological drug safety evaluation respectively. The topics drew the attention to the participants.  Ms. Gao Zhenni, Regulatory Affair Manager of Medicilon, shared her rich experience in the registration of the new drug application during the meeting.

During the meeting, the scholars from Medicilon and the participants had a deep discussion on the topic.  Both parties shared their own views, especially on the registration of new medicines.  This gave the Wuhan Biolake’s pharmaceutical companies a clear impression of Medicilon and laid a good foundation for the future cooperation.